BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming March 9, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Ardent Health, Inc. ("Ardent†or the "Company†) (NYSE: ARDT) securities between July 18, 2024 and November 12, 2025, inclusive (the "Class Period†). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ARDENT HEALTH, INC. (ARDT), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURI ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Ardent to Contact Him Directly to Discuss Their OptionsIf you purchased or acquired securities in Ardent between July 18, 2024 and November 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - January 15, 2026) ...

LOS ANGELES, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Ardent Health, Inc., (“Ardent” or the "Company") (NYSE: ARDT) investors off a class action on behalf of investors that bought securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). Ardent investors have until March 9, 2026 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal right ...

NEW YORK, Jan. 15, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Ardent Health, Inc. (NYSE: ARDT). Shareholders who purchased shares of ARDT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/ardent-health-inc-loss-submission-form/?id=183129&from=4 CLASS PERIOD: July 18, 202 ...

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. for alleged violations of the Securities Exchange Act, specifically for making false and misleading statements regarding its financial reporting [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit is from July 18, 2024, to November 12, 2025, with a deadline for lead plaintiff appointments set for March 9, 2026 [2]. - The complaint alleges that Ardent Health utilized a 180-day cliff on accounts receivable, allowing the company to report inflated amounts and delay loss recognition, rendering its public statements materially misleading [2]. Group 2: Investor Participation - Shareholders who purchased shares during the class period are encouraged to contact the law firm for potential lead plaintiff appointments, although such an appointment is not necessary to participate in any recovery [2][3].

NEW ORLEANS, Jan. 14, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT), if they purchased or otherwise acquired the Company’s securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Middle ...

NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP reminds purchasers or Ardent, Inc. (NYSE: ARDT) (“Ardent”) that a federal securities class action has been filed on behalf of investors who purchased Ardent between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). Investors have until March 9, 2026 to seek appointments as lead plaintiff. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION Nature of the Action: Federal securities class acti ...

New York, New York--(Newsfile Corp. - January 14, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE: ARDT) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-heal ...

SAN DIEGO, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ardent Health, Inc. (NYSE: ARDT) securities between July 18, 2025 and November 12, 2025. Ardent Health and its affiliates operate acute care hospitals and other healthcare facilities. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating All ...

Core Viewpoint - The Ardent Health class action lawsuit alleges that the company and its executives made misleading statements regarding financial practices and liability reserves, leading to significant stock price declines following the revelation of financial discrepancies [3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled Postiwala v. Ardent Health, Inc., and it allows purchasers of Ardent Health securities between July 18, 2024, and November 12, 2025, to seek lead plaintiff status by March 9, 2026 [1][2]. - The lawsuit claims that Ardent Health did not accurately assess the collectability of accounts receivable and misrepresented its financial position [3]. Group 2: Allegations Against Ardent Health - Allegations include that Ardent Health's accounts receivable framework allowed for inflated reporting by utilizing a 180-day cliff for uncollectible accounts [3]. - The company reportedly did not maintain sufficient professional malpractice liability insurance and had inadequate reserves to cover increasing claims due to social inflation in the New Mexico market [3]. - On November 12, 2025, Ardent Health disclosed a $43 million decrease in Q3 2025 revenue and a $57.5 million cut in EBITDA guidance, leading to a nearly 34% drop in stock price [4]. Group 3: Legal Process and Representation - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Ardent Health securities during the class period to seek lead plaintiff status, which enables them to direct the lawsuit on behalf of all class members [5]. - Investors are not required to serve as lead plaintiff to share in any potential recovery from the lawsuit [5]. Group 4: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [6]. - The firm has a strong track record, being ranked 1 in securing monetary relief for investors in securities class action cases [6].